Clinical Trials Directory

Trials / Sponsors / Tempus AI

Tempus AI

Industry · 13 registered clinical trials7 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
2026-01-27
RecruitingEvaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Brea
Breast Cancer, TNBC - Triple-Negative Breast Cancer, HR Positive/HER-2 Negative Breast Cancer
2025-10-27
Active Not RecruitingMulti-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lun
Pulmonary Hypertension, Interstitial Lung Disease (ILD)
N/A2025-07-23
CompletedAddressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform
Aortic Valve Stenosis, Mitral Regurgitation
N/A2024-08-27
RecruitingA Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSC
Head and Neck Squamous Cell Carcinoma
2024-08-01
RecruitingTEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Cancer
2024-06-26
Active Not RecruitingUmbrella Study for Analysis of Data Related to Patients With Cancer
Cancer
2023-12-06
Active Not RecruitingElectrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
Atrial Fibrillation, Structural Heart Disease
N/A2022-09-07
RecruitingTEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Small Cell Lung Cancer
2022-07-13
RecruitingGEMINI-NSCLC: NSCLC Biomarker Study
Non-Small Cell Lung Cancer
2022-06-22
RecruitingTempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Colorectal Cancer
2022-06-21
TerminatedNiraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Solid Tumor, Breast Tumor, Colon Tumor, Malignant
Phase 22022-03-15
Active Not RecruitingTempus Priority Study: A Pan-tumor Observational Study
Breast Cancer, Prostate Cancer, Bladder Cancer
2020-10-19